Medial prefrontal cortex and anteromedial thalamus interaction regulates goal-directed behavior and dopaminergic neuron activity.

Autor: Yang C; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA.; Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, No.1, Xinsi Road, 710038, Xi'an, Shaanxi, P. R. China., Hu Y; Department of Psychology and Behavioral Sciences, Zhejiang University, 310028, Hangzhou, P. R. China.; MR Imaging and Spectroscopy Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Talishinsky AD; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Potter CT; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Calva CB; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Ramsey LA; Ex Vivo Electrophysiology Core, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Kesner AJ; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Don RF; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Junn S; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Tan A; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Pierce AF; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Nicolas C; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Arima Y; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Lee SC; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Su C; Department of Psychology and Behavioral Sciences, Zhejiang University, 310028, Hangzhou, P. R. China., Coudriet JM; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Mejia-Aponte CA; Histology Core, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Wang DV; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Lu H; MR Imaging and Spectroscopy Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Yang Y; MR Imaging and Spectroscopy Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA., Ikemoto S; Neurocircuitry of Motivation Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, 21224, USA. satoshi.ikemoto@nih.gov.

Publikováno v: Nature communications [Nat Commun] 2022 Mar 16; Vol. 13 (1), pp. 1386. Date of Electronic Publication: 2022 Mar 16.

A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease.

Autor: Kulisevsky, Jaime, Martínez-Horta, Saul, Campolongo, Antonia, Pascual-Sedano, Berta, Marín-Lahoz, Juan, Bejr-kasem, Helena, Aracil-Bolaños, Ignacio, Horta-Barba, Andrea, Puig-Davi, Arnau, Pagonabarraga, Javier

Publikováno v: Frontiers in Neurology; 6/2/2022, Vol. 13, p1-11, 11p